Ribonucleic Acid Interference (RNAi) Technology Global Market Report 2026
상품코드:1957757
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
리보핵산 간섭(RNAi) 기술 시장 규모는 최근 급성장하고 있습니다. 2025년 44억 3,000만 달러에서 2026년에는 51억 4,000만 달러에 이르고, CAGR 15.9%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 분자생물학 연구의 발전, RNAi 치료제의 초기 임상 성공, 학술적 유전자 연구 프로그램의 확대, 강력한 스크리닝 라이브러리의 보급, 생명공학 혁신 생태계의 성장에 기인하는 것으로 보입니다.
리보핵산 간섭(RNAi) 기술 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 91억 9,000만 달러에 이르고, CAGR은 15.6%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 RNAi 기반 의약품의 상업화 확대, 희귀질환 치료제 투자 증가, 나노입자 전달 기술 발전, 제약사 간 제휴 증가, 유전자 침묵 치료에 대한 규제 당국의 수용성 향상 등을 꼽을 수 있습니다. 주요 동향으로는 유전자 침묵 요법의 채택 확대, siRNA 기반 의약품 플랫폼의 이용 증가, 정밀의료의 RNAi 기술 통합 심화, 표적형 유전질환 치료 확대, 전달 시스템 최적화 강화 등이 예측됩니다.
표적치료제에 대한 수요 증가는 향후 몇 년간 리보핵산 간섭(RNAi) 기술 시장의 성장을 견인할 것으로 예측됩니다. 표적치료제는 암 및 기타 질환의 분자적 이상을 특이적으로 표적화하여 억제하도록 설계된 치료법으로, 건강한 세포의 손상을 줄이면서 치료의 정확성을 높입니다. 표적치료에 대한 관심이 높아지는 배경에는 개인의 유전자 프로파일에 기반한 맞춤 치료가 가능한 정밀의료의 발전이 크게 기여하고 있습니다. 리보핵산 간섭(RNAi) 기술은 유전성 질환 및 희귀질환 치료에서 정밀한 유전자 침묵을 실현함으로써 표적치료제 수요를 촉진합니다. 이를 통해 높은 특이성과 유효성을 갖춘 치료법 개발이 촉진되고, 맞춤형 의료의 혁신이 촉진되고 있습니다. 예를 들어, 미국에 본사를 둔 비영리 의학 및 과학 단체인 미국 유전자 및 세포치료학회(ASGCT)에 따르면, 2024년 12월 현재 미국 식품의약국(FDA)은 2023년 6개의 유전자 치료 제품을 승인했습니다. 이는 2022년 5건의 승인 건수보다 많은 수치입니다. 이처럼 표적치료제에 대한 수요 증가는 리보핵산 간섭(RNAi) 기술 시장의 성장을 가속하고 있습니다.
리보핵산 간섭(RNAi) 기술 시장에서 활동하는 주요 기업들은 RNAi 치료제의 개발, 공급, 상업화를 효율화하고 다양한 질병 분야에 걸쳐 여러 프로그램의 지속 가능한 파이프라인을 확보하기 위해 전략적 자금 조달 및 지원을 포함한 플랫폼 통합에 집중하고 있습니다. 통합에 집중하고 있습니다. 전략적 자금 조달 및 지원에는 RNA 간섭(RNAi) 치료제의 연구 개발 및 상용화를 가속화하기 위해 벤처 캐피탈, 업계 파트너 및 기타 이해관계자로부터 투자 및 자원을 확보하는 것이 포함됩니다. 예를 들어, 2024년 10월, 미국 소재 바이오 제약사 시티 테라퓨틱스(City Therapeutics)는 RNA 간섭(RNAi) 기반 의약품 개발을 촉진하기 위해 ARCH Venture Partners가 주도하고 다른 저명한 생명과학 투자자들이 참여하는 시리즈 A 펀딩을 통해 미화 1억 3,000만 달러의 투자를 유치했습니다. 1억 3,500만 달러의 투자를 유치했습니다. 이 자금은 간 이외의 조직을 정밀하게 표적화할 수 있도록 설계된 독자적인 지질 나노입자(LNP) 전달 플랫폼을 활용하여 RNAi 기반 치료제 개발을 지원하기 위한 것입니다. 이 플랫폼은 이 분야의 역사적 주요 제약 조건을 해결하고 보다 광범위한 유전성 질환에 대한 치료법 개발을 촉진하기 위해 설계되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Ribonucleic acid interference (RNAi) technology is a biological process that controls gene expression by employing small RNA molecules to silence specific messenger RNA (mRNA) sequences. It is used to modulate gene activity, enabling scientists to silence or decrease the production of targeted proteins. It aids in inhibiting the expression of disease-related genes, making it a valuable tool for genetic research, drug development, and therapeutic applications.
The primary products of ribonucleic acid interference (RNAi) technology include micro ribonucleic acid (miRNA), small interfering ribonucleic acid (siRNA), and others. Micro ribonucleic acid (miRNA) consists of short, non-coding ribonucleic acid molecules that bind to complementary messenger ribonucleic acid sequences to suppress translation or induce degradation, thereby regulating gene expression. The delivery approaches include viral vectors, nanoparticles, chemical modifications, and physical methods, and they are applied in areas such as therapeutics, drug discovery, agriculture, and diagnostics. RNAi technology is extensively utilized by pharmaceutical and biotechnology companies, academic and research institutions, as well as contract research organizations (CROs) and contract manufacturing organizations (CMOs).
Tariffs are impacting the rnai technology market by increasing costs of imported oligonucleotide synthesis equipment, lipid nanoparticle materials, laboratory reagents, and high-precision analytical instruments. North America and Europe are most affected due to dependence on specialized imported research tools, while Asia-Pacific faces cost pressure on contract research and manufacturing services. These tariffs are elevating research and development expenditures and influencing pricing of rnai-based therapies. However, they are also supporting domestic manufacturing of research reagents, regional capability building, and long-term resilience of genetic technology supply chains.
The ribonucleic acid interference (rnai) technology market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid interference (rnai) technology market statistics, including ribonucleic acid interference (rnai) technology industry global market size, regional shares, competitors with a ribonucleic acid interference (rnai) technology market share, detailed ribonucleic acid interference (rnai) technology market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid interference (rnai) technology industry. This ribonucleic acid interference (rnai) technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid interference (rnai) technology market size has grown rapidly in recent years. It will grow from $4.43 billion in 2025 to $5.14 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to advancements in molecular biology research, early clinical success of rnai therapeutics, expansion of academic gene research programs, availability of robust screening libraries, growth of biotech innovation ecosystems.
The ribonucleic acid interference (rnai) technology market size is expected to see rapid growth in the next few years. It will grow to $9.19 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing commercialization of rnai-based drugs, rising investments in rare disease therapeutics, expansion of nanoparticle delivery technologies, growing pharmaceutical partnerships, increasing regulatory acceptance of gene-silencing treatments. Major trends in the forecast period include increasing adoption of gene silencing therapies, rising use of sirna-based drug platforms, growing integration of rnai in precision medicine, expansion of targeted genetic disease treatments, enhanced delivery system optimization.
The growing demand for targeted therapeutics is expected to drive the expansion of the ribonucleic acid interference (RNAi) technology market in the coming years. Targeted therapies are treatments designed to specifically target and inhibit molecular abnormalities in cancer or other diseases, improving treatment precision while reducing damage to healthy cells. The rising emphasis on targeted therapies is largely fueled by advancements in precision medicine, which allow for personalized and more effective treatments based on individual genetic profiles. Ribonucleic Acid Interference (RNAi) Technology boosts the demand for targeted therapeutics by enabling precise gene silencing for the treatment of genetic and rare diseases. It facilitates the development of highly specific and effective therapies, promoting innovation in personalized medicine. For example, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, compared to 5 approvals in 2022. Thus, the increasing demand for targeted therapeutics is fueling the growth of the ribonucleic acid interference (RNAi) technology market.
Major companies operating in the ribonucleic acid interference (RNAi) technology market are concentrating on platform integration, including strategic funding and support, to streamline the development, delivery, and commercialization of RNA interference (RNAi) therapeutics, ensuring a sustainable pipeline of multiple programs across various disease areas. Strategic funding and support involves obtaining investment and resources from venture capital, industry partners, and other stakeholders to accelerate research, development, and commercialization of RNA interference (RNAi) therapeutics. For example, in October 2024, City Therapeutics Inc., a US-based biopharmaceutical company, secured $135 million in Series A financing led by ARCH Venture Partners, with participation from other prominent life sciences investors, to advance RNA interference (RNAi)-based medicine. This funding will support the development of RNAi-based therapies by utilizing its proprietary lipid nanoparticle (LNP) delivery platform, engineered to target tissues beyond the liver with high precision. The platform is designed to address a key historical limitation in the field, facilitating the creation of therapies for a broader range of genetic disorders.
In July 2023, Novartis AG, a Switzerland-based pharmaceutical company, acquired DTx Pharma Inc. for an undisclosed sum. Through this acquisition, Novartis AG intends to enhance its RNAi therapeutic capabilities and broaden its neuromuscular disease portfolio by leveraging DTx Pharma's FALCON delivery platform. DTx Pharma Inc. is a US-based preclinical-stage biotechnology company focused on RNA interference (RNAi) technology for the development of RNAi-based therapeutics.
North America was the largest region in the ribonucleic acid interference (RNAi) technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid interference (rnai) technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid interference (rnai) technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid interference (RNAi) technology consists of revenues earned by entities by providing services such as gene silencing services, custom ribonucleic acid (RNA) synthesis, oligonucleotide design, ribonucleic acid (RNA) sequencing, target validation, functional genomics screening, data analysis, drug discovery support, delivery system optimization, and molecular assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA interference (RNAi) technology market also includes sales of microRNA mimics, transfection reagents, ribonucleic acid (RNA) delivery kits, plasmid vectors, assay kits, cell lines, reagents and buffers, and laboratory consumables. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid Interference (RNAi) Technology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ribonucleic acid interference (rnai) technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ribonucleic acid interference (rnai) technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid interference (rnai) technology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Micro Ribonucleic Acid (miRNA); Small Interfering Ribonucleic Acid (siRNA); Other Products
2) By Delivery Method: Viral Vectors; Nanoparticles; Chemical Modifications; Physical Methods
3) By Application: Therapeutics; Drug Discovery; Agriculture; Diagnostics
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
2) By Small Interfering Ribonucleic Acid (siRNA): Small Interfering Ribonucleic Acid Synthetic Duplexes; Small Interfering Ribonucleic Acid Dicer Substrate Molecules; Small Interfering Ribonucleic Acid Self Delivering Conjugates; Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates
3) By Other Products: Short Hairpin Ribonucleic Acid Expression Constructs; Ribonucleic Acid Interference Screening Libraries; Ribonucleic Acid Interference Transfection Reagents; Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Adoption Of Gene Silencing Therapies
4.2.2 Rising Use Of siRNA-Based Drug Platforms
4.2.3 Growing Integration Of RNAi In Precision Medicine
4.2.4 Expansion Of Targeted Genetic Disease Treatments
4.2.5 Enhanced Delivery System Optimization
5. Ribonucleic Acid Interference (RNAi) Technology Market Analysis Of End Use Industries
5.1 Pharmaceutical And Biotechnology Companies
5.2 Academic And Research Institutes
5.3 Contract Research Organizations
5.4 Contract Manufacturing Organizations
5.5 Diagnostic Developers
6. Ribonucleic Acid Interference (RNAi) Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Ribonucleic Acid Interference (RNAi) Technology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Ribonucleic Acid Interference (RNAi) Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Ribonucleic Acid Interference (RNAi) Technology Market Size, Comparisons And Growth Rate Analysis
7.3. Global Ribonucleic Acid Interference (RNAi) Technology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Ribonucleic Acid Interference (RNAi) Technology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Ribonucleic Acid Interference (RNAi) Technology Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Micro Ribonucleic Acid (miRNA), Small Interfering Ribonucleic Acid (siRNA), Other Products
9.2. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Viral Vectors, Nanoparticles, Chemical Modifications, Physical Methods
9.3. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Therapeutics, Drug Discovery, Agriculture, Diagnostics
9.4. Global Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)
9.5. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Small Interfering Ribonucleic Acid Synthetic Duplexes, Small Interfering Ribonucleic Acid Dicer Substrate Molecules, Small Interfering Ribonucleic Acid Self Delivering Conjugates, Small Interfering Ribonucleic Acid N Acetylgalactosamine Conjugates
9.7. Global Ribonucleic Acid Interference (RNAi) Technology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Short Hairpin Ribonucleic Acid Expression Constructs, Ribonucleic Acid Interference Screening Libraries, Ribonucleic Acid Interference Transfection Reagents, Micro Ribonucleic Acid And Small Interfering Ribonucleic Acid Research Kits
10. Ribonucleic Acid Interference (RNAi) Technology Market Regional And Country Analysis
10.1. Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Ribonucleic Acid Interference (RNAi) Technology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Ribonucleic Acid Interference (RNAi) Technology Market
12.1. China Ribonucleic Acid Interference (RNAi) Technology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Ribonucleic Acid Interference (RNAi) Technology Market
13.1. India Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Ribonucleic Acid Interference (RNAi) Technology Market
14.1. Japan Ribonucleic Acid Interference (RNAi) Technology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Ribonucleic Acid Interference (RNAi) Technology Market
15.1. Australia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market
16.1. Indonesia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Ribonucleic Acid Interference (RNAi) Technology Market
17.1. South Korea Ribonucleic Acid Interference (RNAi) Technology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Ribonucleic Acid Interference (RNAi) Technology Market
19.1. South East Asia Ribonucleic Acid Interference (RNAi) Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market
20.1. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Ribonucleic Acid Interference (RNAi) Technology Market
21.1. UK Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market
26.1. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Ribonucleic Acid Interference (RNAi) Technology Market
27.1. Russia Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Ribonucleic Acid Interference (RNAi) Technology Market
28.1. North America Ribonucleic Acid Interference (RNAi) Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Ribonucleic Acid Interference (RNAi) Technology Market
29.1. USA Ribonucleic Acid Interference (RNAi) Technology Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Ribonucleic Acid Interference (RNAi) Technology Market
31.1. South America Ribonucleic Acid Interference (RNAi) Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Ribonucleic Acid Interference (RNAi) Technology Market
32.1. Brazil Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Ribonucleic Acid Interference (RNAi) Technology Market
33.1. Middle East Ribonucleic Acid Interference (RNAi) Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Ribonucleic Acid Interference (RNAi) Technology Market
34.1. Africa Ribonucleic Acid Interference (RNAi) Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Ribonucleic Acid Interference (RNAi) Technology Market, Segmentation By Product, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
